Edward H Myles's Net Worth
$7.05 Million
Who is Edward H Myles?
Edward H Myles has an estimated net worth of $7.05 Million. This is based on reported shares across multiple companies, which include Scholar Rock Holding Corp, AMAG PHARMACEUTICALS, INC., PRESSURE BIOSCIENCES INC, and Ocata Therapeutics, Inc..
SEC CIK
Edward H Myles's CIK is 0001358219
Past Insider Trading and Trends
2021 was Edward H Myles's most active year for acquiring shares with 5 total transactions. Edward H Myles's most active month to acquire stocks was the month of January. 2021 was Edward H Myles's most active year for disposing of shares, totalling 9 transactions. Edward H Myles's most active month to dispose stocks was the month of October. 2023 saw Edward H Myles paying a total of $121,082.04 for 173,664 shares, this is the most they've acquired in one year. In 2021 Edward H Myles cashed out on 156,602 shares for a total of $2,751,300.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Scholar Rock Holding Corp (SRRK) Snapshot price: $16.06
COO & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.48% | -9.46K |
$8.98 | -$84,978.24 | 201.52K |
Jun 17
| |||
Form 4
| -2.20% | -4.74K |
$15.74 | -$74,685.74 | 210.98K |
Feb 16
| |||
Form 4
| +33.04% | 53.57K |
—
|
—
| 215.72K |
Feb 12
| |||
Form 4
| -3.93% | -6.63K |
$15.93 | -$105,669.67 | 162.15K |
Jan 16
| |||
Form 4
|
—
|
0
|
$11.85 | -$174,082.36 | 168.78K |
Scheduled
|
Dec 29
| ||
Form 4
|
—
|
0
|
$11.20 | -$315,737.61 | 168.78K |
Scheduled
|
Dec 7
| ||
Form 4
| -17.18% | -35.01K |
$12.51 | -$438,039.09 | 168.78K |
Scheduled
|
Nov 2
| ||
Form 4
| -3.38% | -7.14K |
$8.75 | -$62,456.07 | 203.79K |
Jun 21
| |||
Form 4
| +43.31% | 63.75K |
—
|
—
| 210.93K |
Feb 13
| |||
Form 4
| -4.57% | -7.04K |
$11.29 | -$79,503.50 | 147.18K |
Jan 17
| |||
Form 4
| +94.06% | 74.75K |
—
|
—
| 154.22K |
Jun 16
| |||
Form 4
| +261.70% | 57.5K |
—
|
—
| 79.47K |
Feb 14
| |||
Form 4
| -9.02% | -2.18K |
$19.46 | -$42,390.20 | 21.97K |
Jan 18
| |||
Form 4
|
—
|
0
|
$35.14 | -$2,751,300.13 | 24.15K |
Scheduled
|
Nov 11 - Nov 15
| ||
Form 4
|
∞
| 24.15K |
—
|
—
| 24.15K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS, INC. No price found
COO & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +43.69% | 30K |
—
|
—
| 98.66K |
Mar 10
| |||
Form 4
| -1.47% | -1.02K |
$7.75 | -$7,912.75 | 68.66K |
Mar 2
| |||
Form 4
| -2.84% | -2.25K |
$9.09 | -$20,488.74 | 77.18K |
Feb 23 - Feb 25
| |||
Form 4
| -2.41% | -1.96K |
$12.47 | -$24,491.08 | 79.43K |
Apr 11
| |||
Form 4
| -1.29% | -1.06K |
$14.76 | -$15,704.64 | 81.4K |
Mar 2
| |||
Form 4
| +63.42% | 32K |
—
|
—
| 82.46K |
Feb 25
| |||
Form 4
| -1.69% | -869.00 |
$15.51 | -$13,478.19 | 50.46K |
Feb 23
| |||
Form 4
| -3.69% | -1.96K |
$19.85 | -$38,985.40 | 51.33K |
Jul 2
| |||
Form 4
| +56.07% | 19.15K |
$21.00 | -$17,934.00 | 53.29K |
Mar 2
| |||
Form 4
| -6.22% | -2.18K |
$18.55 | -$40,383.35 | 32.82K |
May 8
| |||
Form 4
| +75.00% | 15K |
—
|
—
| 35K |
Feb 23
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRESSURE BIOSCIENCES INC (PBIO) Snapshot price: $0.3349
Senior VP Finance & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
| +100.00% | 1K |
$3.00 | $3,000.00 | 2K |
Sep 7
| |||
Form 4
|
∞
| 1K |
$3.00 | $3,000.00 |
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ocata Therapeutics, Inc. No price found
COO & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -56.00K |
$8.50 | -$476,000.00 |
0
|
Feb 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
∞
| 56K |
—
|
—
| 56K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||